Unlock your business growth with non-dilutive funding opportunities. Grant Engine's team of experts specializes in NIH & SBIR Grant Writing and Grant management.
Eagle Point Funding is a consulting firm connecting companies and academia to fitting R&D federal grant and contract opportunities. We assist organizations to identify, write winning applications, and engage in a multi-submission strategy in order to max
Revenue-based investment for fast growing B2B and B2C companies. Non-equity, non-dilutive, founder-focused.
Novel' Capital Intelligence Platform provides software companies access to growth capital via our non-dilutive funding products or curated connections to VCs via VentureMatch(TM)"
Ryan helps innovative businesses secure tax incentives and non-dilutive funding with expert guidance, using our Assess, Advise, and Transform model for growth and compliance.
We initiate many client collaborations with a Strategic Non-Dilutive Funding Plan, allowing our Scientific Grants Experts to forge a solid connection with the client and grasp their scientific goals, funding requirements, project scope, and timelines. Our Experts then align a comprehensive plan to mee...
Founders First Capital Partners offers up to $2 million of funding to diverse-led businesses prepared for growth. As a premium, national lender, we specialize in providing non-dilutive capital and expert advisory services to scale your business.
Other Disclosures © 2025 Lighter Capital. All Rights Reserved. RevenueLoan® is a registered trademark of Lighter Capital, Inc. For California borrowers, loans are made or arranged by Lighter Capital, Inc. pursuant to its California Finance Lenders Law License, #603K634....
Dilutive capital is funding that involves giving up a percentage of ownership in your business. Non-dilutive capital does not involve equity, so it allows you to use the money received and run your business with complete control. While both dilutive and non-dilutive capital have benefits, the ...
Conclusion NIH SBIR/STTR grants are an essential source of external non-dilutive funding for pediatric device innovation and especially for academic-initiated projects. This funding can provide needed early-stage support to facilitate commercialization. In addition, these grants can serve as achievable ...